BR8907255A - Complexos de acido aminofosfonico macrociclico,sua preparacao,formulacoes e uso - Google Patents

Complexos de acido aminofosfonico macrociclico,sua preparacao,formulacoes e uso

Info

Publication number
BR8907255A
BR8907255A BR898907255A BR8907255A BR8907255A BR 8907255 A BR8907255 A BR 8907255A BR 898907255 A BR898907255 A BR 898907255A BR 8907255 A BR8907255 A BR 8907255A BR 8907255 A BR8907255 A BR 8907255A
Authority
BR
Brazil
Prior art keywords
formulations
preparation
acid complexes
aminophosphonic acid
macrocyclic aminophosphonic
Prior art date
Application number
BR898907255A
Other languages
English (en)
Inventor
Jaime Simon
David A Wilson
Joseph R Garlich
David E Troutner
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of BR8907255A publication Critical patent/BR8907255A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR898907255A 1988-12-19 1989-12-15 Complexos de acido aminofosfonico macrociclico,sua preparacao,formulacoes e uso BR8907255A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
PCT/US1989/005782 WO1990006776A1 (en) 1988-12-19 1989-12-15 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use

Publications (1)

Publication Number Publication Date
BR8907255A true BR8907255A (pt) 1991-03-12

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
BR898907255A BR8907255A (pt) 1988-12-19 1989-12-15 Complexos de acido aminofosfonico macrociclico,sua preparacao,formulacoes e uso

Country Status (26)

Country Link
US (1) US5059412A (pt)
EP (2) EP0408701B1 (pt)
JP (1) JP2515929B2 (pt)
KR (1) KR0178966B1 (pt)
CN (1) CN1025983C (pt)
AR (1) AR248140A1 (pt)
AT (1) ATE112689T1 (pt)
AU (3) AU639899B2 (pt)
BR (1) BR8907255A (pt)
CA (1) CA2005880C (pt)
CY (1) CY1902A (pt)
DE (1) DE68918852T2 (pt)
DK (1) DK175479B1 (pt)
ES (1) ES2061010T3 (pt)
FI (1) FI101857B1 (pt)
HK (1) HK146795A (pt)
HU (1) HU207454B (pt)
IE (2) IE940833L (pt)
IL (1) IL92784A (pt)
MX (1) MX18786A (pt)
NO (1) NO180434C (pt)
NZ (1) NZ231818A (pt)
PT (1) PT92619B (pt)
SA (1) SA91120234B1 (pt)
WO (1) WO1990006776A1 (pt)
ZA (1) ZA899734B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
IE912054A1 (en) * 1990-06-18 1991-12-18 Dow Chemical Co The use of macrocyclic aminophosphonic acid complexes as¹imaging agents
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5874573A (en) * 1995-06-26 1999-02-23 Concat, Inc. Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
WO2002062398A2 (en) * 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
WO2002055112A2 (en) * 2001-01-09 2002-07-18 Bristol Myers Squibb Co Polypodal chelants for metallopharmaceuticals
AU2002364552A1 (en) 2001-12-13 2003-06-30 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
PT3054996T (pt) 2013-10-07 2023-08-01 Igl Pharma Inc Processo para preparar agentes ósseos terapêuticos de alta pureza
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
EP3302496B1 (en) * 2015-05-25 2021-01-06 IGL Pharma, Inc. Dotmp kit formulations for radioisotopes
PL3519394T3 (pl) 2016-09-27 2020-11-30 Bayer Pharma Aktiengesellschaft Sposób wytwarzania krystalicznej postaci o modyfikacji a kalkobutrolu
EP3579886A4 (en) 2017-02-08 2020-11-25 IGL Pharma, Inc. METHOD OF USE FOR THERAPEUTIC BONE ASSOCIATION

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
SU1098937A1 (ru) * 1983-03-25 1984-06-23 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова 1,4,7,10-Тетра/диоксифосфорилметил/-1,4,7,10-тетраазациклододекан в качестве комплексона дл св зывани катионов меди /п/,кобальта /п/,кадми /п/,свинца /п/ и лантана /ш/
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
ZA852799B (en) * 1984-06-04 1986-12-30 Dow Chemical Co Organic amine phosphonic acid complexes for the treatment of calcific tumors
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
EP0375376A3 (en) 1991-06-12
ZA899734B (en) 1991-08-28
IE66391B1 (en) 1995-12-27
EP0375376A2 (en) 1990-06-27
JPH03502936A (ja) 1991-07-04
FI904084A0 (fi) 1990-08-17
NO903632L (no) 1990-10-17
AU4700989A (en) 1990-06-21
IL92784A0 (en) 1990-09-17
DK175479B1 (da) 2004-11-08
AU639899B2 (en) 1993-08-12
JP2515929B2 (ja) 1996-07-10
NO903632D0 (no) 1990-08-17
EP0408701B1 (en) 1994-10-12
CA2005880C (en) 1999-01-05
ES2061010T3 (es) 1994-12-01
CY1902A (en) 1989-12-15
PT92619A (pt) 1990-06-29
AU4828290A (en) 1990-07-10
CN1046739A (zh) 1990-11-07
NO180434B (no) 1997-01-13
KR910700073A (ko) 1991-03-13
DE68918852T2 (de) 1995-05-11
NO180434C (no) 1997-04-23
EP0408701A1 (en) 1991-01-23
FI101857B (fi) 1998-09-15
NZ231818A (en) 1992-05-26
HU901163D0 (en) 1991-03-28
PT92619B (pt) 1995-09-12
AU657641B2 (en) 1995-03-16
IL92784A (en) 1994-08-26
HU207454B (en) 1993-04-28
IE940833L (en) 1990-06-19
WO1990006776A1 (en) 1990-06-28
CN1025983C (zh) 1994-09-28
US5059412A (en) 1991-10-22
KR0178966B1 (ko) 1999-03-20
DK195990D0 (da) 1990-08-16
AR248140A1 (es) 1995-06-30
FI101857B1 (fi) 1998-09-15
CA2005880A1 (en) 1990-06-19
DK195990A (da) 1990-08-16
MX18786A (es) 1993-12-01
HK146795A (en) 1995-09-22
HUT54897A (en) 1991-04-29
EP0408701A4 (en) 1991-07-31
DE68918852D1 (de) 1994-11-17
AU5068593A (en) 1994-02-24
SA91120234B1 (ar) 2004-09-04
ATE112689T1 (de) 1994-10-15
IE894063L (en) 1990-06-19

Similar Documents

Publication Publication Date Title
BR8907255A (pt) Complexos de acido aminofosfonico macrociclico,sua preparacao,formulacoes e uso
ES2015056B3 (es) Pañal de un solo uso
BR8701302A (pt) Compostos macrolideos,sua preparacao e seu uso
DK518988A (da) Vanduoploeseligt polypeptidpraeparat
DK314089D0 (da) Orale praeparater
AU587622B2 (en) Isoxazole and furan derivatives, their preparation and use as antiviral agents
DK489189D0 (da) Farmaceutisk praeparat
DK540389A (da) Immunstimulerende praeparat
NO890505D0 (no) Vandig blekepreparat.
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
DK15988A (da) Diuretisk praeparat
DE68905091T2 (de) Kosmetisches praeparat.
DK336489D0 (da) Farmaceutisk praeparat
DK16489A (da) Immunstimulerende praeparat.
DK606288D0 (da) Praeparat
ZA879721B (en) 2-nitro-5-(substituted phenoxy)benzohydroximate derivatives and their use as herbicide
DE3824370A1 (de) Dermatologisches praeparat
DK189289D0 (da) Substituerede thiourinstoffer
IL83411A0 (en) Benzohydroxamic acid derivatives,their preparation and their use as herbicides
DK343689D0 (da) Herbicidt praeparat
DK638889A (da) Farmaceutisk kombinationspraeparat
IL83500A0 (en) Phenoxybenzoic acid derivatives,their preparation and their use as herbicides
ES293182Y (es) Asiento-inodoro de uso infantil
DK131289D0 (da) Substituerede thiourinstofderivater
GB8826320D0 (en) Soluble herbicidal preparations

Legal Events

Date Code Title Description
FC Decision: refusal
CKFC Appeal: appeal against refusal
FA Application withdrawn
B15K Others concerning applications: alteration of classification

Ipc: A61K 51/04 (2006.01), C07F 9/38 (2006.0